**Core Concept**
Drug-induced lupus erythematosus (DILE) is a rare autoimmune disorder triggered by medications, characterized by the production of various autoantibodies, similar to those found in systemic lupus erythematosus (SLE). This condition highlights the complex interplay between pharmacological agents and the immune system.

**Why the Correct Answer is Right**
The correct answer is related to the specific autoantibodies associated with DILE. These autoantibodies are directed against nuclear antigens, such as histones, and can mimic the immune response seen in SLE. The production of these autoantibodies is a key feature of DILE, and their presence can help differentiate this condition from other autoimmune disorders. The specific autoantibodies involved in DILE include anti-histone, anti-Ro (SS-A), and anti-La (SS-B) antibodies.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is not a recognized autoantibody associated with DILE. While anti-SS-A and anti-SS-B antibodies are indeed found in DILE, they are not the primary autoantibodies associated with this condition.
* **Option B:** Anti-Sm antibodies are characteristic of SLE, but not typically associated with DILE. The presence of anti-Sm antibodies can help differentiate SLE from DILE.
* **Option C:** This option is not a recognized autoantibody associated with DILE. While various autoantibodies can be found in DILE, this is not a specific or relevant autoantibody for this condition.

**Clinical Pearl / High-Yield Fact**
One important clinical correlation to remember is that the symptoms of DILE can be similar to those of SLE, but often resolve once the offending medication is discontinued. This highlights the importance of considering medication-induced lupus as a potential cause of autoimmune symptoms.

**Correct Answer: C. Anti-histone antibodies.